Target intelligence / Profile preview

Upstream binding transcription factor (UBTF)

Target
UBTF
Molecular classification
Transcription factor, HMG-box DNA-binding protein family
01

Overview

Upstream binding transcription factor (UBTF) is a member of the HMG-box DNA-binding protein family and functions as a key transcription factor regulating ribosomal RNA synthesis within the nucleolus. UBTF forms part of the pre-initiation complex and recruits RNA polymerase I to rDNA promoters, activating transcription. It also plays roles in chromatin remodeling and pre-rRNA processing. UBTF has two isoforms (UBTF1 and UBTF2); UBTF1 primarily regulates rRNA transcription (via RNA polymerase I), while UBTF2 affects mRNA transcription (via RNA polymerase II). Pathogenic de novo gain-of-function variants in UBTF1 are associated with severe, childhood-onset neurodegenerative and neurodevelopmental disorders, involving language, motor, and cognitive regression, often accompanied by brain atrophy and mitochondrial dysfunction. Merely altering UBTF expression—via overexpression or loss-of-function—can be deleterious to neural development and cellular metabolism. There are currently no approved drugs targeting UBTF directly. The rare identification of decreased CSF biopterin may act as a biomarker for UBTF1-related disease.

Other names
UBFUBF1UBF-1UBF2NOR-90Autoantigen NOR-90Nucleolar transcription factor 1Upstream-binding factor 190-kDa nucleolus organizer region autoantigenCONDBA
02

Mechanism of action

Not currently targeted by approved drugs; pathogenic variants act via gain-of-function leading to increased rRNA expression

03

Biological functions

Ribosomal RNA (rRNA) transcriptionChromatin remodelingRecruitment of RNA polymerase I to rDNA promoterRNA bindingPre-rRNA processing
04

Disease associations

Neurodegeneration (childhood-onset, with brain atrophy)Rare syndromic intellectual disabilityPotential role in mitochondrial dysfunction
05

Safety considerations

Gain-of-function or abolished activity associated with severe neurodevelopmental and neurodegenerative disorders
06

Biomarkers

Decreased biopterin in CSF (proposed biomarker for UBTF1 neurodevelopmental disorder)

Beyond the preview

Go deeper on Upstream binding transcription factor (UBTF).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Upstream binding transcription factor (UBTF).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call